Dosage specifications and description of applicable patient groups of DaliRasen (Keweike)
Daridorexant is a new type of oral dual hypnotic, which is an Orexin receptor antagonist (DORA) and is mainly used to treat insomnia. It inhibits wakefulness signals by selectively blocking the Orexin receptors 1 and receptors 2, thereby helping patients fall asleep faster and stay asleep longer. Compared with traditional benzodiazepines, Daliramen has the advantages of rapid onset of action, low dependence, and low risk of next-day drowsiness, and is suitable for long-term treatment of patients with insomnia.
DaliRasen is available in oral tablet form on the market, with common specifications of 10mg, 25mg and 50mg, which facilitates doctors to adjust the dosage according to the patient's condition and tolerance. It is usually recommended to take it once before bedtime to ensure a good night's sleep. The tablets are designed to be easy to swallow and have good oral bioavailability, allowing the drug to exert its hypnotic effects in a short period of time.

DaliRasen is mainly suitable for adult patients with insomnia, especially those who have difficulty falling asleep or falling asleep again after waking up at night. Clinical studies show it is equally effective in older patients without significantly affecting cognitive function or next-day alertness. In addition, for patients with mild depression or anxiety accompanied by insomnia, DaliRasen can also improve sleep structure, thereby indirectly alleviating daytime dysfunction.
Although DaliRasen is relatively safe, it still needs to be used as directed by a doctor. Patients with hepatic insufficiency or combined use of other central nervous system depressants should adjust the dose under the guidance of a physician. At the same time, patients who drive or operate machinery need to pay attention to changes in alertness after the drug takes effect. Overall, DaliRasen provides a scientific and safe treatment option for insomnia patients with its convenient dosage form, flexible dosage and good tolerance.
Reference materials:https://www.drugs.com/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)